PUBLISHER: Inkwood Research | PRODUCT CODE: 1936075
PUBLISHER: Inkwood Research | PRODUCT CODE: 1936075
The North America magnetic resonance imaging (MRI) systems market size is valued at $2,978.08 million as of 2026 and is expected to reach $4,615.81 million by 2034, progressing with a CAGR of 5.63% during the forecast years, 2026-2034.
Advanced healthcare infrastructure, combined with robust reimbursement frameworks, positions North America as the dominant MRI systems market globally. Rising chronic disease prevalence, particularly neurological and cardiovascular conditions, accelerates demand for sophisticated diagnostic imaging capabilities across the region. Moreover, favorable regulatory environments established by the FDA streamline market entry for innovative MRI technologies.
Healthcare facilities increasingly prioritize patient-centric imaging solutions featuring enhanced comfort, faster scan times, and AI-powered diagnostic accuracy. Additionally, the shift toward value-based care models encourages investments in equipment that improves diagnostic precision while reducing overall healthcare costs. Consequently, hospitals and outpatient imaging centers modernize their MRI fleets to capture growing procedure volumes efficiently.
REGIONAL ANALYSIS
The North America magnetic resonance imaging (MRI) systems market growth assessment includes the analysis of the United States and Canada.
The United States commands the largest share within the North America MRI systems market, driven by extensive healthcare expenditure and widespread adoption of advanced medical technologies. Medicare coverage for MRI procedures ensures patient access while supporting facility investments in state-of-the-art equipment. However, recent reimbursement pressures have reshaped purchasing decisions across imaging providers significantly.
Healthcare facilities increasingly evaluate the total cost of ownership when selecting between high-field and ultra-high-field systems. Furthermore, the proliferation of outpatient imaging centers creates competitive market dynamics beyond traditional hospital radiology departments. These independent facilities prioritize compact, patient-friendly MRI architectures that maximize throughput without compromising diagnostic quality.
Academic medical centers and research institutions continue driving demand for ultra-high-field systems supporting cutting-edge neuroscience and oncology research. Additionally, rural healthcare providers face persistent challenges accessing advanced imaging technologies despite telemedicine integration efforts. The FDA's regulatory framework requires manufacturers to obtain 510(k) clearance before commercializing new MRI systems in the United States. This premarket notification process ensures safety and effectiveness while maintaining reasonable market entry timelines for qualified manufacturers.
Further, Canada demonstrates strong growth potential within the North America magnetic resonance imaging systems market despite a smaller installed base compared to its southern neighbor. Provincial healthcare systems coordinate MRI equipment procurement through centralized decision-making processes that prioritize population health needs.
Wait times for non-urgent MRI examinations remain elevated in certain provinces, creating opportunities for capacity expansion investments. Moreover, public-private partnerships increasingly facilitate diagnostic imaging infrastructure development across urban and rural communities. Canadian healthcare providers emphasize systems offering versatility across multiple clinical applications to maximize equipment utilization rates.
The aging population, coupled with rising cancer incidence, drives sustained demand for oncological and neurological MRI procedures. Additionally, indigenous communities require improved access to advanced diagnostic technologies through mobile or satellite imaging programs. Collectively, these factors play a vital role in boosting the magnetic resonance imaging (MRI) systems market growth in North America during the forecast years.
The North America magnetic resonance imaging (MRI) systems market is segmented into architecture, field type, and application. The architecture segment is further categorized into closed MRI systems and open MRI systems.
Closed MRI systems play a pivotal role in the North American market landscape due to their superior imaging capabilities and established clinical workflows. Standard bore configurations measuring 60 centimeters in diameter accommodate the majority of patient populations while delivering exceptional diagnostic quality. These systems provide the highest signal-to-noise ratios essential for detailed neurological, musculoskeletal, and abdominal imaging protocols.
Hospital radiology departments rely heavily on closed MRI architectures for comprehensive diagnostic capabilities across all clinical specialties. Moreover, technological advancements have enhanced patient comfort within closed systems through improved bore access, ambient lighting, and entertainment options. Wide bore alternatives offering 70-centimeter apertures address claustrophobia concerns while accommodating bariatric patients more comfortably.
On the other hand, healthcare facilities increasingly invest in wide bore systems, recognizing their ability to reduce sedation requirements and examination cancellations. Furthermore, closed MRI systems support advanced sequences, including diffusion-weighted imaging, functional MRI, and cardiac imaging that demand high magnetic field homogeneity. Research institutions particularly value closed architectures for investigational studies requiring precise imaging specifications. Consequently, closed MRI systems maintain market leadership despite growing interest in alternative configurations.
Some of the top players operating in the North America magnetic resonance imaging (MRI) systems market include Siemens Healthineers, GE Healthcare, Philips Healthcare, Canon Medical Systems Corp, etc.
Siemens Healthineers operates as a leading medical technology company headquartered in Erlangen, Germany, with substantial North American operations. The company manufactures comprehensive MRI system portfolios spanning 0.55T to 7T field strengths for diverse clinical applications. Siemens' flagship MAGNETOM family includes innovative products like the MAGNETOM Free.Max, featuring ultra-low helium consumption technology.
Their systems incorporate syngo.MR software platforms enabling AI-powered workflow optimization and advanced imaging capabilities. Moreover, Siemens maintains extensive service networks ensuring rapid technical support across healthcare facilities throughout the United States and Canada. The company's research collaborations with academic medical centers drive continuous innovation in MRI technology development.
COMPANY PROFILES